Feedback
Settings

Settings

Goto Application

1. WO2009051671 - IMPROVED METHODS OF PRODUCING RPE CELLS AND COMPOSITIONS OF RPE CELLS

PermaLink
Publication Number WO/2009/051671
Publication Date 23.04.2009
International Application No. PCT/US2008/011669
International Filing Date 10.10.2008
IPC
C12N 5/02 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
02Propagation of single cells or cells in suspension; Maintenance thereof; Culture media therefor
C12N 5/071 2010.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07Animal cells or tissues
071Vertebrate cells or tissues, e.g. human cells or tissues
CPC
A61K 35/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
A61K 35/30
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
A61P 25/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
14for treating abnormal movements, e.g. chorea, dyskinesia
16Anti-Parkinson drugs
A61P 27/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
A61P 27/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
06Antiglaucoma agents or miotics
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applicants
  • ADVANCED CELL TECHNOLOGY, INC. [US]/[US] (AllExceptUS)
  • MALCUIT, Christopher [US]/[US] (UsOnly)
  • LEMIEUX, Linda [US]/[US] (UsOnly)
  • HOLMES, Willliam [US]/[US] (UsOnly)
  • HUERTAS, Pedro [US]/[US] (UsOnly)
  • VILNER, Lucy [US]/[US] (UsOnly)
Inventors
  • MALCUIT, Christopher
  • LEMIEUX, Linda
  • HOLMES, Willliam
  • HUERTAS, Pedro
  • VILNER, Lucy
Agents
  • TESKIN, Robin, L.
Priority Data
60/998,66812.10.2007US
60/998,76612.10.2007US
61/009,90802.01.2008US
61/009,91102.01.2008US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) IMPROVED METHODS OF PRODUCING RPE CELLS AND COMPOSITIONS OF RPE CELLS
(FR) PROCÉDÉS AMÉLIORÉS POUR LA PRODUCTION DE CELLULES RPE ET DE COMPOSITIONS DE CELLULES RPE
front page image
Abstract
(EN)
The present invention provides improved methods for producing RPE cells from human embryonic stem cells or from other human pluripotent stem cells. The invention also relates to human retinal pigmented epithelial cells derived from human embryonic stem cells or other human multipotent or pluripotent stem cells. hRPE cells derived from embryonic stem cells are molecularly distinct from adult and fetal-derived RPE cells, and are also distinct from embryonic stem cells. The hRPE cells described herein are useful for treating retinal degenerative diseases.
(FR)
La présente invention concerne des procédés améliorés pour la production de cellules RPE à partir de cellules souches d'embryon humain ou d'autres cellules souches pluripotentes humaines. L'invention a également pour objets des cellules épithéliales pigmentées de rétine humaine (hRPE) dérivées de cellules souches d'embryon humain ou d'autres cellules souches multipotentes ou pluripotentes humaines. Les cellules hRPE dérivées de cellules souches embryonnaires sont distinctes d'un point de vue moléculaire des cellules RPE dérivées d'adultes et de fœtus, et sont également distinctes des cellules souches embryonnaires. Les cellules hRPE décrites dans les présentes sont utiles au traitement de maladies dégénérescentes de la rétine.
Also published as
AU2008312007
AU2015201435
AU2017202874
AU2019226198
CA2702386
CA3006687
CN101878295
CN104946591
DK2209888
EP2209888
EP3636748
ES2764473
IL204956
IL246181
IN1547/KOLNP/2010
IN201838006942
IN201838006943
JP2011500024
JP2014168482
JP2017136088
JP2020115882
KR1020100065373
KR1020160045933
PT2209888
SG160666
US20110274662
US20150086512
US20190062703
US3340055
Latest bibliographic data on file with the International Bureau
# -